Jan, Asad <br/><br/>
eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response.  [electronic resource] 

 -  Acta neuropathologica  01 2017 
 - 101-119 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0533 
<br/><br/><label>Standard No.: </label>10.1007/s00401-016-1634-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--enzymology<br/>Amyloid beta-Peptides--genetics<br/>Animals<br/>Animals, Genetically Modified<br/>Caenorhabditis elegans<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Elongation Factor 2 Kinase--antagonists & inhibitors<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Frontal Lobe--drug effects<br/>Hippocampus--drug effects<br/>Humans<br/>Kelch-Like ECH-Associated Protein 1--metabolism<br/>Male<br/>NF-E2-Related Factor 2--metabolism<br/>Neurons--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Oxidative Stress--drug effects<br/>Peptide Fragments--genetics<br/>Reactive Oxygen Species